A M I No 16.59/2025 26 Paclitaxel Albubound Inj 100mg With Reconstitution Kit
Tender Title | A M I No 16.59/2025 26 Paclitaxel Albubound Inj 100mg With Reconstitution Kit | ||
Tender ID | NA | Tender Reference Number | 82251025 |
Tender Type | Open/advertised | ||
Tender Opening Date | 2025-01-23 06:24 AM | Tender Closing Date | 2025-03-10 05:30 AM |
Tender Value | Refer Document | Tender Location | New Delhi , Central Delhi , Delhi |
Tender Category | Goods | Product Category | Healthcare and Medicine Tenders |
ePublished Date | 2025-01-23 06:24 AM | Bid Opening Date | 2025-03-10 05:30 AM |
Document Download Start Date | 2025-01-23 06:24 AM | Document Download End Date | 2025-03-10 05:30 AM |
Bid Submission Start Date | 2025-01-23 06:24 AM | Bid Submission End Date | 2025-03-10 05:30 AM |
Clarification start Date | Clarification End Date | ||
Bid Validity Period (in Days) | NA |
Tender Fee | Refer document |
EMD (Earnest Money Deposit) | ₹ 2,04,290 |
EMD Fee Type | NA |
Payment Instruments/Mode | NA |
Work Description - For Complete Deion And Other Details, Please Refer To Tender
The Ministry of Railways, Stores/Northern Railway (2nd Floor, Annexe-I Baroda House, KG Marg, New Delhi), invites tenders for the supply of A MI No - 16.59/2025-26 Paclitaxel AlbuBound Inj 100mg with Reconstitution Kit (Tender Reference Number: 82251025). This open tender (Tender Category: Goods; Product Category: Railway related Products) requires a bid security (EMD) of ₹204,290. The tender document is available for download from January 23rd, 2025, 11:54 AM to March 10th, 2025, 11:00 AM. Bids must be submitted within the same timeframe, with the opening scheduled for March 10th, 2025, 11:00 AM. For complete details, please refer to the tender document. No tender fee is applicable.
Get Hassle free financing for your business
Office Inviting Bids | Stores/northern Rly |
Address | 2nd Floor, Annexe- I Baroda House, K G Marg New Delhi |
Contact Details | NA |
NA | |
Website | NA |
A M I No - 16.64/-2025-26 Pembrolizumab Inj 100mg..read more
A M I No. 16.14/2025-26 Cetuximab Inj 100mg..read more
A M I No -gr. 16 N 16/2025-26 Trastuzumab Deruxtecan Inj..read more
A M I No. 2025-26 Tab./cap. Lorlatinib 100mg..read more
A M I No. 12.208 / 2025-26 Tab./cap. Canagliflozin 100mg..read more
All the major brands in each raw material category